ZNF692 and nonpapillary renal cell carcinoma: MYC binding to the promoter of ZNF692 drives ZNF692 overexpression in clear cell renal carcinoma (ccRCC) cells and in turn, ZNF692 promotes ccRCC proliferation through transcriptional repression of interferon regulatory factor 4 and fms-related receptor tyrosine kinase 4 (Wang et al. 2023).